Genome Editing Market Analysis and Outlook 2020-2027

1
Genome Editing Market Growth, Share, Demand and
Analysis of Key Players Forecasts to 2027
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
Increasing genomic research across the globe
coupled with high incidence of target diseases is
expected to stimulate market growth Genome
Editing Market Size USD 3.8 billion in 2018,
Market Growth - CAGR of 14.8, Market Trends
Partnerships and research for advanced genetic
engineering technologies
3
Our Approach
Market Summary

• The global Genome Editing market is expected to
  reach USD 10.1 billion by 2026, according to a
  new report by Reports and Data. Genome editing
  refers to a genetic engineering method used for
  insertion, deletion, or modification in the
  genome of any organism. Genome editing has come
  up as promising tool with wide scale application
  of established genetic engineering technologies
  such as TALEN and introduction of new methods
  such as CRISPR technology.
• The market is driven by the increasing incidence
  of genetic diseases, favorable funding scenario
  for research development in the field of
  genetic engineering, technological advancements
  in genetic engineering such as developments in
  CRISPR technology, increasing focus of food
  industry on genetically modified organisms, and
  rising awareness about efficacy as well
  applications of genetic engineering methods. For
  instance, globally over 175 million hectares of
  land is used for GM crops production. However,
  stringent regulatory scenario and ethical
  concerns for gene editing research and
  applications and concerns among end users
  regarding use of gene alteration therapies are
  likely to hinder the market growth during the
  forecast period.
• Key participants include Thermo Fisher Scientific
  Inc., Merck KGaA, GenScript, Horizon Discovery
  Group Plc, Integrated DNA Technologies, Inc,
  Lonza, New England Biolabs and Sangamo
  Therapeutics, Inc.
• Fill in your details to get your hands on an
  Exclusive Sample of this Report _at_
  https//www.reportsanddata.com/sample-enquiry-form
  /1052

4
Our Approach
Market Summary

• For the purpose of this report, Reports and Data
  has segmented the Genetic Editing market on the
  basis of type, application, end user and region
• Type Outlook (Revenue, USD Million, 2016 - 2026)
• Clustered Regularly Interspaced Short Palindromic
  Repeats (CRISPR)
• Transcription Activator-Like Effector Nucleases
  (TALEN)
• Zinc Finger Nucleases (ZFN)
• Others
• Application Outlook (Revenue, USD Million, 2016 -
  2026)
• Animal Genetic Engineering
• Therapeutic Application
• Genetically Modified Organisms
• Plant Genetic Engineering
• Cell Line Engineering

5
Our Approach
Market Summary

• End User Outlook (Revenue, USD Million, 2016 -
  2026)Pharma-Biotech CompaniesAcademic
  Institutes Research CenterAgrigenomic
  CompaniesContract Research Organizations
• Regional Outlook (Revenue, USD Million, 2016 -
  2026)
• North AmericaEuropeAsia PacificLatin
  AmericaMiddle East Africa
• Do you have questions about the Report or want to
  inquire about a Discount? Ask our Expert
  https//www.reportsanddata.com/discount-enquiry-fo
  rm/1052

6
Our Approach
Market Summary

• Further key findings from the report suggest
• CRISPR market is rising at a high growth rate of
  30.9 percent in Asia Pacific followed by North
  America and Europe. Rising application of genetic
  engineering for therapeutics will drive the
  demand for the market during forecast period
  across all regions.
• The valuation for TALEN market was USD 1.79
  billion in 2018 and is expected to grow to USD
  2.01 billion by 2026. Benefits associated with
  TALEN high degrees of precision and control, is
  the key factor supporting the wide-scale adoption
  of the technology and consequently contributing
  to the market growth.
• Asia Pacific is expected to witness a CAGR of
  15.8 percent in the forecast period. Emerging
  markets such China and Japan are likely to
  witness high growth
• Regional regulatory approval is another key
  regulatory factor for adoption and growth of
  genetic editing in the region.
• Key participants include Thermo Fisher Scientific
  Inc., Merck KGaA, GenScript, Horizon Discovery
  Group Plc, Integrated DNA Technologies, Inc,
  Lonza, New England Biolabs and Sangamo
  Therapeutics, Inc.
• Read More _at_ https//www.reportsanddata.com/report-
  detail/genome-editing-market

7
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com